Lobbying

Tandem Diabetes Care TNDM's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2024; the issues it reports most are Budget/Appropriations and Medicare/Medicaid.

Tandem Diabetes CareTNDM

Tandem Diabetes Care stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$150K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2024
The first quarter a report named it

Lobbying by quarter

Tandem Diabetes Care lobbying by quarter
Tandem Diabetes Care lobbying by quarter
QuarterAmountReports
Q4 2024$20K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$50K1
Q2 2026$50K1
Q3 2026$00

By issue

  • Budget and appropriations$150K · 6 reports
  • Medicare and Medicaid$150K · 6 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE6 reports
  • Centers For Medicare and Medicaid Services (CMS)5 reports
  • Health & Human Services, Dept of (HHS)4 reports
  • Office of Management & Budget (OMB)4 reports
  • Executive Office of the President (EOP)2 reports

Firms it paid

Firm
The Nickles Group$320K7 quarters

Former officials lobbying for it

Former position
NICOLE WRIGHTU.S. Senator Marco Rubio, Legislative Assistant, Legislative Aide, Legislative Correspondent, and Intern; U.S. Rep. Brian Mast, Staff Assistant; U.S House Committee on Foreign Affairs, Intern; U.S. Rep./Minority Leader Kevin McCarthy, InternQ1 2025

Lobbying reports

Filed by
07/15for Q2The Nickles Group$50K
04/15for Q1The Nickles Group$50K
01/20for Q4 2025The Nickles Group$50K
25/10/09for Q3 2025The Nickles Group$50K
25/07/17for Q2 2025The Nickles Group$50K
25/04/17for Q1 2025The Nickles Group$50K
25/01/21for Q4 2024The Nickles Group$20K
25/01/21for Q4 2024The Nickles GroupUnder $5,000